Immutep (IMMP) Net Shares Issued and Repurchased (2011 - 2025)
Immutep (IMMP) posted Net Shares Issued and Repurchased of $359.6 million for Q4 2025, up 3.07% on a QoQ basis from $348.9 million in Q2 2025, and up 1.25% year-over-year from $355.1 million in Q4 2024.
Immutep (IMMP) Net Shares Issued and Repurchased (2011 - 2025) Analysis & Trends
Immutep's Net Shares Issued and Repurchased history runs 15 years deep, the most recent figure standing at $359.6 million for Q4 2025.
- Quarterly Net Shares Issued and Repurchased rose 1.25% year-over-year to $359.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $359.6 million (up 1.25% YoY) and the FY2025 annual result came in at $348.9 million, down 2.35% from the prior year.
- Net Shares Issued and Repurchased was $359.6 million for Q4 2025 at Immutep, up from $348.9 million in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $359.6 million in Q4 2025 and bottomed at $241.4 million in Q2 2021.
- A 5-year average of $302.4 million and a median of $294.5 million in 2023 frame the typical range for Net Shares Issued and Repurchased.
- Annual changes were most pronounced in 2021 — Net Shares Issued and Repurchased soared 51.55% — and 2022, when it retreated 8.58%.
- Immutep's Net Shares Issued and Repurchased stood at $266.2 million in 2021, then decreased by 8.58% to $243.3 million in 2022, then grew by 19.52% to $290.8 million in 2023, then advanced by 22.12% to $355.1 million in 2024, then climbed by 1.25% to $359.6 million in 2025.
- Business Quant data shows IMMP's Net Shares Issued and Repurchased at $359.6 million in Q4 2025, $348.9 million in Q2 2025, and $355.1 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Immutep | 561.65 Mn | 561.65 Mn | - | 359.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 359.58 Mn |
| Dec 31, 2025 | 359.58 Mn |
| Jun 30, 2025 | 348.86 Mn |
| Jun 30, 2025 | 348.86 Mn |
| Dec 31, 2024 | 355.14 Mn |
| Dec 31, 2024 | 355.14 Mn |
| Jun 30, 2024 | 357.26 Mn |
| Jun 30, 2024 | 357.26 Mn |
| Dec 31, 2023 | 290.80 Mn |
| Dec 31, 2023 | 290.80 Mn |
| Jun 30, 2023 | 298.27 Mn |
| Jun 30, 2023 | 298.27 Mn |
| Dec 31, 2022 | 243.32 Mn |
| Dec 31, 2022 | 243.32 Mn |
| Jun 30, 2022 | 263.16 Mn |
| Jun 30, 2022 | 263.16 Mn |
| Dec 31, 2021 | 266.16 Mn |
| Dec 31, 2021 | 266.16 Mn |
| Jun 30, 2021 | 241.35 Mn |
| Jun 30, 2021 | 241.35 Mn |